FYLNETRA FDA approval date

The FDA approved FYLNETRA on 26 May 2022.

FDA approval date
26 May 2022

Drug identity has not yet been verified against registry records

Also recorded as PEGFILGRASTIM-PBBK

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-05-26DayFYLNETRAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761084", "applicant_as_listed_by_fda": "KASHIV BIOSCIENCES LLC", "brand_names": ["FYLNETRA"], "active_ingredients": ["PEGFILGRASTIM-PBBK"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220526", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026